Expressed Competent Cells Market - Global Outlook and Forecast 2023-2027

Report ID: 831070 | Published Date: Mar 2026 | No. of Page: 102 | Base Year: 2025 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Introduction to Research & Analysis Reports
    1.1 Expressed Competent Cells Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Expressed Competent Cells Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Expressed Competent Cells Overall Market Size
    2.1 Global Expressed Competent Cells Market Size: 2021 VS 2027
    2.2 Global Expressed Competent Cells Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Expressed Competent Cells Players in Global Market
    3.2 Top Global Expressed Competent Cells Companies Ranked by Revenue
    3.3 Global Expressed Competent Cells Revenue by Companies
    3.4 Top 3 and Top 5 Expressed Competent Cells Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Expressed Competent Cells Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Expressed Competent Cells Players in Global Market
        3.6.1 List of Global Tier 1 Expressed Competent Cells Companies
        3.6.2 List of Global Tier 2 and Tier 3 Expressed Competent Cells Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Expressed Competent Cells Market Size Markets, 2021 & 2027
        4.1.2 20*100μl
        4.1.3 50*100μl
        4.1.4 100*100μl
        4.1.5 Other
    4.2 By Type - Global Expressed Competent Cells Revenue & Forecasts
        4.2.1 By Type - Global Expressed Competent Cells Revenue, 2016-2021
        4.2.2 By Type - Global Expressed Competent Cells Revenue, 2022-2027
        4.2.3 By Type - Global Expressed Competent Cells Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Expressed Competent Cells Market Size, 2021 & 2027
        5.1.2 Protein Expression
        5.1.3 Other
    5.2 By Application - Global Expressed Competent Cells Revenue & Forecasts
        5.2.1 By Application - Global Expressed Competent Cells Revenue, 2016-2021
        5.2.2 By Application - Global Expressed Competent Cells Revenue, 2022-2027
        5.2.3 By Application - Global Expressed Competent Cells Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Expressed Competent Cells Market Size, 2021 & 2027
    6.2 By Region - Global Expressed Competent Cells Revenue & Forecasts
        6.2.1 By Region - Global Expressed Competent Cells Revenue, 2016-2021
        6.2.2 By Region - Global Expressed Competent Cells Revenue, 2022-2027
        6.2.3 By Region - Global Expressed Competent Cells Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Expressed Competent Cells Revenue, 2016-2027
        6.3.2 US Expressed Competent Cells Market Size, 2016-2027
        6.3.3 Canada Expressed Competent Cells Market Size, 2016-2027
        6.3.4 Mexico Expressed Competent Cells Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Expressed Competent Cells Revenue, 2016-2027
        6.4.2 Germany Expressed Competent Cells Market Size, 2016-2027
        6.4.3 France Expressed Competent Cells Market Size, 2016-2027
        6.4.4 U.K. Expressed Competent Cells Market Size, 2016-2027
        6.4.5 Italy Expressed Competent Cells Market Size, 2016-2027
        6.4.6 Russia Expressed Competent Cells Market Size, 2016-2027
        6.4.7 Nordic Countries Expressed Competent Cells Market Size, 2016-2027
        6.4.8 Benelux Expressed Competent Cells Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Expressed Competent Cells Revenue, 2016-2027
        6.5.2 China Expressed Competent Cells Market Size, 2016-2027
        6.5.3 Japan Expressed Competent Cells Market Size, 2016-2027
        6.5.4 South Korea Expressed Competent Cells Market Size, 2016-2027
        6.5.5 Southeast Asia Expressed Competent Cells Market Size, 2016-2027
        6.5.6 India Expressed Competent Cells Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Expressed Competent Cells Revenue, 2016-2027
        6.6.2 Brazil Expressed Competent Cells Market Size, 2016-2027
        6.6.3 Argentina Expressed Competent Cells Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Expressed Competent Cells Revenue, 2016-2027
        6.7.2 Turkey Expressed Competent Cells Market Size, 2016-2027
        6.7.3 Israel Expressed Competent Cells Market Size, 2016-2027
        6.7.4 Saudi Arabia Expressed Competent Cells Market Size, 2016-2027
        6.7.5 UAE Expressed Competent Cells Market Size, 2016-2027
7 Players Profiles
    7.1 Merck KGaA
        7.1.1 Merck KGaA Corporate Summary
        7.1.2 Merck KGaA Business Overview
        7.1.3 Merck KGaA Expressed Competent Cells Major Product Offerings
        7.1.4 Merck KGaA Expressed Competent Cells Revenue in Global (2016-2021)
        7.1.5 Merck KGaA Key News
    7.2 Thermo Fisher Scientific
        7.2.1 Thermo Fisher Scientific Corporate Summary
        7.2.2 Thermo Fisher Scientific Business Overview
        7.2.3 Thermo Fisher Scientific Expressed Competent Cells Major Product Offerings
        7.2.4 Thermo Fisher Scientific Expressed Competent Cells Revenue in Global (2016-2021)
        7.2.5 Thermo Fisher Scientific Key News
    7.3 Agilent Technologies
        7.3.1 Agilent Technologies Corporate Summary
        7.3.2 Agilent Technologies Business Overview
        7.3.3 Agilent Technologies Expressed Competent Cells Major Product Offerings
        7.3.4 Agilent Technologies Expressed Competent Cells Revenue in Global (2016-2021)
        7.3.5 Agilent Technologies Key News
    7.4 Takara Bio
        7.4.1 Takara Bio Corporate Summary
        7.4.2 Takara Bio Business Overview
        7.4.3 Takara Bio Expressed Competent Cells Major Product Offerings
        7.4.4 Takara Bio Expressed Competent Cells Revenue in Global (2016-2021)
        7.4.5 Takara Bio Key News
    7.5 Promega Corporation
        7.5.1 Promega Corporation Corporate Summary
        7.5.2 Promega Corporation Business Overview
        7.5.3 Promega Corporation Expressed Competent Cells Major Product Offerings
        7.5.4 Promega Corporation Expressed Competent Cells Revenue in Global (2016-2021)
        7.5.5 Promega Corporation Key News
    7.6 Beijing TransGen Biotech
        7.6.1 Beijing TransGen Biotech Corporate Summary
        7.6.2 Beijing TransGen Biotech Business Overview
        7.6.3 Beijing TransGen Biotech Expressed Competent Cells Major Product Offerings
        7.6.4 Beijing TransGen Biotech Expressed Competent Cells Revenue in Global (2016-2021)
        7.6.5 Beijing TransGen Biotech Key News
    7.7 GeneScript Corporation
        7.7.1 GeneScript Corporation Corporate Summary
        7.7.2 GeneScript Corporation Business Overview
        7.7.3 GeneScript Corporation Expressed Competent Cells Major Product Offerings
        7.4.4 GeneScript Corporation Expressed Competent Cells Revenue in Global (2016-2021)
        7.7.5 GeneScript Corporation Key News
    7.8 Yeastern Biotech
        7.8.1 Yeastern Biotech Corporate Summary
        7.8.2 Yeastern Biotech Business Overview
        7.8.3 Yeastern Biotech Expressed Competent Cells Major Product Offerings
        7.8.4 Yeastern Biotech Expressed Competent Cells Revenue in Global (2016-2021)
        7.8.5 Yeastern Biotech Key News
    7.9 New England Biolabs
        7.9.1 New England Biolabs Corporate Summary
        7.9.2 New England Biolabs Business Overview
        7.9.3 New England Biolabs Expressed Competent Cells Major Product Offerings
        7.9.4 New England Biolabs Expressed Competent Cells Revenue in Global (2016-2021)
        7.9.5 New England Biolabs Key News
    7.10 QIAGEN N.V.
        7.10.1 QIAGEN N.V. Corporate Summary
        7.10.2 QIAGEN N.V. Business Overview
        7.10.3 QIAGEN N.V. Expressed Competent Cells Major Product Offerings
        7.10.4 QIAGEN N.V. Expressed Competent Cells Revenue in Global (2016-2021)
        7.10.5 QIAGEN N.V. Key News
    7.11 OriGene Technologies
        7.11.1 OriGene Technologies Corporate Summary
        7.11.2 OriGene Technologies Business Overview
        7.11.3 OriGene Technologies Expressed Competent Cells Major Product Offerings
        7.11.4 OriGene Technologies Expressed Competent Cells Revenue in Global (2016-2021)
        7.11.5 OriGene Technologies Key News
    7.12 Lucigen
        7.12.1 Lucigen Corporate Summary
        7.12.2 Lucigen Business Overview
        7.12.3 Lucigen Expressed Competent Cells Major Product Offerings
        7.12.4 Lucigen Expressed Competent Cells Revenue in Global (2016-2021)
        7.12.5 Lucigen Key News
    7.13 Zymo Research
        7.13.1 Zymo Research Corporate Summary
        7.13.2 Zymo Research Business Overview
        7.13.3 Zymo Research Expressed Competent Cells Major Product Offerings
        7.13.4 Zymo Research Expressed Competent Cells Revenue in Global (2016-2021)
        7.13.5 Zymo Research Key News
    7.14 Bio-Rad Laboratories
        7.14.1 Bio-Rad Laboratories Corporate Summary
        7.14.2 Bio-Rad Laboratories Business Overview
        7.14.3 Bio-Rad Laboratories Expressed Competent Cells Major Product Offerings
        7.14.4 Bio-Rad Laboratories Expressed Competent Cells Revenue in Global (2016-2021)
        7.14.5 Bio-Rad Laboratories Key News
    7.15 Bioline
        7.15.1 Bioline Corporate Summary
        7.15.2 Bioline Business Overview
        7.15.3 Bioline Expressed Competent Cells Major Product Offerings
        7.15.4 Bioline Expressed Competent Cells Revenue in Global (2016-2021)
        7.15.5 Bioline Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Expressed Competent Cells Market Opportunities & Trends in Global Market
    Table 2. Expressed Competent Cells Market Drivers in Global Market
    Table 3. Expressed Competent Cells Market Restraints in Global Market
    Table 4. Key Players of Expressed Competent Cells in Global Market
    Table 5. Top Expressed Competent Cells Players in Global Market, Ranking by Revenue (2019)
    Table 6. Global Expressed Competent Cells Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. Global Expressed Competent Cells Revenue Share by Companies, 2016-2021
    Table 8. Global Companies Expressed Competent Cells Product Type
    Table 9. List of Global Tier 1 Expressed Competent Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Expressed Competent Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global Expressed Competent Cells Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - Expressed Competent Cells Revenue in Global (US$, Mn), 2016-2021
    Table 13. By Type - Expressed Competent Cells Revenue in Global (US$, Mn), 2022-2027
    Table 14. By Application – Global Expressed Competent Cells Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - Expressed Competent Cells Revenue in Global (US$, Mn), 2016-2021
    Table 16. By Application - Expressed Competent Cells Revenue in Global (US$, Mn), 2022-2027
    Table 17. By Region – Global Expressed Competent Cells Revenue, (US$, Mn), 2021 VS 2027
    Table 18. By Region - Global Expressed Competent Cells Revenue (US$, Mn), 2016-2021
    Table 19. By Region - Global Expressed Competent Cells Revenue (US$, Mn), 2022-2027
    Table 20. By Country - North America Expressed Competent Cells Revenue, (US$, Mn), 2016-2021
    Table 21. By Country - North America Expressed Competent Cells Revenue, (US$, Mn), 2022-2027
    Table 22. By Country - Europe Expressed Competent Cells Revenue, (US$, Mn), 2016-2021
    Table 23. By Country - Europe Expressed Competent Cells Revenue, (US$, Mn), 2022-2027
    Table 24. By Region - Asia Expressed Competent Cells Revenue, (US$, Mn), 2016-2021
    Table 25. By Region - Asia Expressed Competent Cells Revenue, (US$, Mn), 2022-2027
    Table 26. By Country - South America Expressed Competent Cells Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - South America Expressed Competent Cells Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - Middle East & Africa Expressed Competent Cells Revenue, (US$, Mn), 2016-2021
    Table 29. By Country - Middle East & Africa Expressed Competent Cells Revenue, (US$, Mn), 2022-2027
    Table 30. Merck KGaA Corporate Summary
    Table 31. Merck KGaA Expressed Competent Cells Product Offerings
    Table 32. Merck KGaA Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 33. Thermo Fisher Scientific Corporate Summary
    Table 34. Thermo Fisher Scientific Expressed Competent Cells Product Offerings
    Table 35. Thermo Fisher Scientific Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 36. Agilent Technologies Corporate Summary
    Table 37. Agilent Technologies Expressed Competent Cells Product Offerings
    Table 38. Agilent Technologies Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 39. Takara Bio Corporate Summary
    Table 40. Takara Bio Expressed Competent Cells Product Offerings
    Table 41. Takara Bio Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 42. Promega Corporation Corporate Summary
    Table 43. Promega Corporation Expressed Competent Cells Product Offerings
    Table 44. Promega Corporation Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 45. Beijing TransGen Biotech Corporate Summary
    Table 46. Beijing TransGen Biotech Expressed Competent Cells Product Offerings
    Table 47. Beijing TransGen Biotech Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 48. GeneScript Corporation Corporate Summary
    Table 49. GeneScript Corporation Expressed Competent Cells Product Offerings
    Table 50. GeneScript Corporation Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 51. Yeastern Biotech Corporate Summary
    Table 52. Yeastern Biotech Expressed Competent Cells Product Offerings
    Table 53. Yeastern Biotech Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 54. New England Biolabs Corporate Summary
    Table 55. New England Biolabs Expressed Competent Cells Product Offerings
    Table 56. New England Biolabs Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 57. QIAGEN N.V. Corporate Summary
    Table 58. QIAGEN N.V. Expressed Competent Cells Product Offerings
    Table 59. QIAGEN N.V. Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 60. OriGene Technologies Corporate Summary
    Table 61. OriGene Technologies Expressed Competent Cells Product Offerings
    Table 62. OriGene Technologies Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 63. Lucigen Corporate Summary
    Table 64. Lucigen Expressed Competent Cells Product Offerings
    Table 65. Lucigen Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 66. Zymo Research Corporate Summary
    Table 67. Zymo Research Expressed Competent Cells Product Offerings
    Table 68. Zymo Research Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 69. Bio-Rad Laboratories Corporate Summary
    Table 70. Bio-Rad Laboratories Expressed Competent Cells Product Offerings
    Table 71. Bio-Rad Laboratories Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
    Table 72. Bioline Corporate Summary
    Table 73. Bioline Expressed Competent Cells Product Offerings
    Table 74. Bioline Expressed Competent Cells Revenue (US$, Mn), (2016-2021)
List of Figures
    Figure 1. Expressed Competent Cells Segment by Type
    Figure 2. Expressed Competent Cells Segment by Application
    Figure 3. Global Expressed Competent Cells Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Expressed Competent Cells Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global Expressed Competent Cells Revenue, 2016-2027 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Expressed Competent Cells Revenue in 2020
    Figure 8. By Type - Global Expressed Competent Cells Revenue Market Share, 2016-2027
    Figure 9. By Application - Global Expressed Competent Cells Revenue Market Share, 2016-2027
    Figure 10. By Region - Global Expressed Competent Cells Revenue Market Share, 2016-2027
    Figure 11. By Country - North America Expressed Competent Cells Revenue Market Share, 2016-2027
    Figure 12. US Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 13. Canada Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 14. Mexico Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 15. By Country - Europe Expressed Competent Cells Revenue Market Share, 2016-2027
    Figure 16. Germany Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 17. France Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 18. U.K. Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 19. Italy Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 20. Russia Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 21. Nordic Countries Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 22. Benelux Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 23. By Region - Asia Expressed Competent Cells Revenue Market Share, 2016-2027
    Figure 24. China Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 25. Japan Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 26. South Korea Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 27. Southeast Asia Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 28. India Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 29. By Country - South America Expressed Competent Cells Revenue Market Share, 2016-2027
    Figure 30. Brazil Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 31. Argentina Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 32. By Country - Middle East & Africa Expressed Competent Cells Revenue Market Share, 2016-2027
    Figure 33. Turkey Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 34. Israel Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 35. Saudi Arabia Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 36. UAE Expressed Competent Cells Revenue, (US$, Mn), 2016-2027
    Figure 37. Merck KGaA Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 38. Thermo Fisher Scientific Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 39. Agilent Technologies Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 40. Takara Bio Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 41. Promega Corporation Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 42. Beijing TransGen Biotech Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 43. GeneScript Corporation Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 44. Yeastern Biotech Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 45. New England Biolabs Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 46. QIAGEN N.V. Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 47. OriGene Technologies Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 48. Lucigen Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 49. Zymo Research Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 50. Bio-Rad Laboratories Expressed Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Expressed Competent Cells Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Expressed Competent Cells Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Expressed Competent Cells Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports